Genetic products company, Affymetrix Inc. (AFFX), inked a ‘Powered by Affymetrix’ (“PbA”) Program agreement with Korea-based biotechnology company, DNA Link Inc. Following the terms of the deal, DNA ...

Affymetrix Inc. and Partners HealthCare have announced that they have entered into a three-year translational research collaboration to develop microarray-based diagnostics for complex diseases such ...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Affymetrix, Inc. (NAS: AFFX) and DNA Link, Inc., a Korean genomics-based biotechnology company, today announced that they have signed a Powered by Affymetrix TM ...

Offerings Now Encompass Multiplex and Parallel Analysis of Cells, Proteins, and Genes Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research since ...

Affymetrix Inc. has announced that a research group led by scientists at Johns Hopkins School of Medicine and the NIH used Affymetrix GeneChip® microarrays to discover that eight of the stem cell ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix (Nasdaq:AFFX) and Ariosa Diagnostics, Inc. today announced the signing of a multi-year supply agreement covering Affymetrix arrays and instruments to ...

Affymetrix Inc. announced that the US Food and Drug Administration (FDA) has granted regulatory clearance to its GCS3000Dx (GCSDx) platform for in vitro gene expression diagnostic testing. The ...

Following the Silicon Valley pattern of jamming more power into less space, Santa Clara's Affymetrix will disclose today that it has packed most of the human genome onto two DNA chips. Previously, ...

Affymetrix, Inc. and DNA Link, Inc., a Korean genomics-based biotechnology company, have signed a Powered by Affymetrix (PbA) Programme agreement in which DNA Link, Inc. obtains a worldwide license to ...

Affymetrix and DNA Link Sign Partnership for Forensic Test Development for Human Identification SANTA CLARA, Calif.--(BUSINESS WIRE)-- Affymetrix, Inc. (NAS: AFFX) and DNA Link, Inc., a Korean ...